MedPlus Health Services Limited has announced a temporary three-day suspension of the drug license for one of its stores operated by its subsidiary, Optival Health Solutions Private Limited. The store, located in Mallapur, Telangana, received the order on May 15, 2026. The suspension follows alleged non-compliance with the Drugs and Cosmetics Act. The company anticipates a potential revenue impact of Rs 2.49 lacs resulting from this short-term operational closure.
Suspension Details
The company informed stakeholders that a specific retail outlet under its subsidiary, Optival Health Solutions Private Limited, has been issued a three-day suspension of its operating drug license. The action was initiated by the Assistant Director of the Drugs Control Administration in Shameerpet, Telangana. The formal order was received by the company on May 15, 2026.
Operational and Financial Impact
The suspension pertains to a store located in Mallapur, Telangana, for alleged violations under Rule 65 of the Drugs and Cosmetics Act, 1940, and associated regulations. While the disruption is limited to a duration of three days, the company has quantified the potential financial impact to be approximately Rs 2.49 lacs in lost revenue. MedPlus remains committed to regulatory compliance across its network and is taking necessary steps to address the matters raised by the authorities.
Source: BSE
